• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.57% Nasdaq Down 0.25%

    Anacor Pharmaceuticals, Inc. (ANAC)

    -NasdaqGM
    38.02 Down 0.54(1.40%) 2:48PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:38.56
    Open:38.44
    Bid:38.04 x 200
    Ask:38.11 x 200
    1y Target Est:36.75
    Beta:2.04
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:37.09 - 39.21
    52wk Range:13.19 - 39.21
    Volume:326,607
    Avg Vol (3m):500,802
    Market Cap:1.63B
    P/E (ttm):30.39
    EPS (ttm):1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ANACDown 1.40%1.63B
    JNJDown 1.03%283.63B
    NVSDown 1.05%235.35B
    SNYDown 1.28%121.77B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):84.70
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.40
    Quarterly EPS Est (Dec-14) :-0.61
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.98

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback